SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-18-019062
Filing Date
2018-10-30
Accepted
2018-10-30 16:51:42
Documents
2
Period of Report
2018-10-25
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K navb20181030_8k.htm 8-K 24117
2 EXHIBIT 99.1 ex_126940.htm EX-99.1 12808
  Complete submission text file 0001437749-18-019062.txt   38224
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35076 | Film No.: 181147547
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences